Dyne Therapeutics (DYN) News Today $12.38 -0.12 (-0.96%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$12.38 -0.01 (-0.04%) As of 08/15/2025 05:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DYN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN1 hour ago | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYNAugust 13 at 12:41 PM | globenewswire.comDyne Therapeutics Advances DMD Treatment with DYNE-251 StudyAugust 13 at 12:39 PM | tipranks.comDyne Therapeutics, Inc. (NASDAQ:DYN) Receives Average Rating of "Buy" from BrokeragesAugust 12, 2025 | americanbankingnews.comDyne Therapeutics, Inc. (NASDAQ:DYN) Receives Consensus Rating of "Buy" from AnalystsAugust 12, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYNAugust 11, 2025 | prnewswire.comXTX Topco Ltd Takes $330,000 Position in Dyne Therapeutics, Inc. (NASDAQ:DYN)August 11, 2025 | marketbeat.comDyne Therapeutics (DYN) to Release Quarterly Earnings on MondayAugust 10, 2025 | americanbankingnews.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYNAugust 9, 2025 | globenewswire.comDyne Therapeutics (NASDAQ:DYN) Given New $13.00 Price Target at OppenheimerAugust 8, 2025 | americanbankingnews.comDyne Therapeutics (NASDAQ:DYN) Sees Strong Trading Volume - Here's WhyAugust 7, 2025 | marketbeat.comOppenheimer Cuts Dyne Therapeutics (NASDAQ:DYN) Price Target to $13.00August 7, 2025 | marketbeat.comDyne Therapeutics trading halted, volatility trading pauseAugust 7, 2025 | msn.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYNAugust 6, 2025 | prnewswire.comDyne Therapeutics Gains FDA Breakthrough Designation for DYNE-251August 5, 2025 | theglobeandmail.comDyne Therapeutics (DYN) Projected to Post Earnings on MondayAugust 5, 2025 | marketbeat.comTD Asset Management Inc Cuts Holdings in Dyne Therapeutics, Inc. (NASDAQ:DYN)August 5, 2025 | marketbeat.comDyne Therapeutics stock rises after FDA grants breakthrough therapy statusAugust 4, 2025 | investing.comDyne gets FDA breakthrough therapy status for DMD therapyAugust 4, 2025 | msn.comDyne Therapeutics Shares Rise 3.6% After FDA Grants Breakthrough Therapy StatusAugust 4, 2025 | msn.comDyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-251 in Duchenne Muscular Dystrophy (DMD)August 4, 2025 | globenewswire.comGSA Capital Partners LLP Buys New Shares in Dyne Therapeutics, Inc. (NASDAQ:DYN)August 2, 2025 | marketbeat.comEquities Analysts Set Expectations for DYN FY2025 EarningsAugust 2, 2025 | marketbeat.comDyne Therapeutics (NASDAQ:DYN) Price Target Cut to $36.00 by Analysts at Stifel NicolausAugust 1, 2025 | marketbeat.comHC Wainwright Has Optimistic Outlook of DYN Q3 EarningsAugust 1, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYNJuly 31, 2025 | prnewswire.comAegis Wealth Management LLC Takes $348,000 Position in Dyne Therapeutics, Inc. (NASDAQ:DYN)July 31, 2025 | marketbeat.comDyne Therapeutics (NASDAQ:DYN) Price Target Cut to $23.00 by Analysts at Royal Bank Of CanadaJuly 30, 2025 | marketbeat.comDyne Therapeutics (NASDAQ:DYN) Earns Outperform Rating from Raymond James FinancialJuly 30, 2025 | marketbeat.comDyne Therapeutics (NASDAQ:DYN) Given New $38.00 Price Target at Chardan CapitalJuly 30, 2025 | marketbeat.comDyne Therapeutics (NASDAQ:DYN) Posts Earnings Results, Beats Expectations By $0.02 EPSJuly 29, 2025 | marketbeat.comDyne Therapeutics (NASDAQ:DYN) Shares Down 6.7% - What's Next?July 29, 2025 | marketbeat.comDyne Therapeutics price target lowered to $23 from $25 at RBC CapitalJuly 29, 2025 | msn.comDyne Therapeutics Advances in Neuromuscular TherapiesJuly 29, 2025 | msn.comDyne Therapeutics, Inc.: Dyne Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business HighlightsJuly 29, 2025 | finanznachrichten.deDyne Therapeutics extends cash runway as it advances key drug programsJuly 28, 2025 | za.investing.comDyne Reports Wider Loss in Fiscal Q2July 28, 2025 | fool.comDyne Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business HighlightsJuly 28, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYNJuly 28, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYNJuly 27, 2025 | prnewswire.comDyne Therapeutics (NASDAQ:DYN) Trading Up 7.2% - Time to Buy?July 26, 2025 | marketbeat.comY Intercept Hong Kong Ltd Purchases 70,897 Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN)July 26, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYNJuly 22, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYNJuly 17, 2025 | prnewswire.comSatellos Bioscience names new chief medical officerJuly 16, 2025 | msn.comSatellos Appoints Dr. Wildon Farwell as Chief Medical OfficerJuly 16, 2025 | businesswire.comInsider Buying: Dyne Therapeutics, Inc. (NASDAQ:DYN) CEO Acquires 100,000 Shares of StockJuly 16, 2025 | insidertrades.comDyne Therapeutics, Inc. (NASDAQ:DYN) CEO John Cox Buys 100,000 SharesJuly 15, 2025 | marketbeat.comDyne Therapeutics (NASDAQ:DYN) Shares Down 6.1% on Analyst DowngradeJuly 15, 2025 | marketbeat.comJPMorgan Chase & Co. Issues Pessimistic Forecast for Dyne Therapeutics (NASDAQ:DYN) Stock PriceJuly 15, 2025 | marketbeat.com Get Dyne Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DYN and its competitors with MarketBeat's FREE daily newsletter. Email Address DYN Media Mentions By Week DYN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DYN News Sentiment▼0.490.61▲Average Medical News Sentiment DYN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DYN Articles This Week▼97▲DYN Articles Average Week Get Dyne Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DYN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Rhythm Pharmaceuticals News Today Avidity Biosciences News Today Nuvalent News Today Axsome Therapeutics News Today CRISPR Therapeutics News Today Merus News Today Abivax News Today Viking Therapeutics News Today TG Therapeutics News Today ACADIA Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DYN) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredJPMorgan: Gold to $4,250—Here’s the Real PlayGold Surges And Some Investors Are Getting Paid, But Most Are Not. Which One Do You Want to Be? Gold prices ar...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dyne Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dyne Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access